STRATEGIC PLANNING

Before even considering opportunities in the Chinese biotechnology/pharmaceutical market, your company's primary objective must be to maximize the potential of your IP portfolio and internal resources/capabilities. Symbios examines your current positioning in the industry through due diligence and quantitative business/competitive intelligence, and we work closely with you to evaluate and formulate a strategic plan that fits your desired goals.

Regardless of your strategic objectives or options, from differentiation advantage and strategic positioning by "owning” a therapeutic class …to "owning” a market competency…to horizontal or vertical integration, Symbios helps clients design a detailed strategic plan along with milestones and metrics that will make sure your organization is successfully managing and expanding its core resources and capabilities.

We also offer advice on R&D management strategy to ensure that the right projects are being funded and that the true value of a technological platform is realized. For start-ups and academic spin-offs, our Business Plan services assist in preparing a solid business model and supporting content necessary to undertake your critical steps towards growth and commercialization.

Services that fall under this category include:

• Entry/Exit Strategies
• Patent/IP Strategic Options Articulation
• Business Intelligence and Due Diligence
• R&D Management and Pipeline Strategy Optimization
• Business Plan Development and Updating